105 related articles for article (PubMed ID: 32553686)
21. STUB1 is essential for T-cell activation by ubiquitinating CARMA1.
Wang S; Li Y; Hu YH; Song R; Gao Y; Liu HY; Shu HB; Liu Y
Eur J Immunol; 2013 Apr; 43(4):1034-41. PubMed ID: 23322406
[TBL] [Abstract][Full Text] [Related]
22. Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling.
Yin J; Oh YT; Kim JY; Kim SS; Choi E; Kim TH; Hong JH; Chang N; Cho HJ; Sa JK; Kim JC; Kwon HJ; Park S; Lin W; Nakano I; Gwak HS; Yoo H; Lee SH; Lee J; Kim JH; Kim SY; Nam DH; Park MJ; Park JB
Cancer Res; 2017 Sep; 77(18):4973-4984. PubMed ID: 28754668
[TBL] [Abstract][Full Text] [Related]
23. STUB1 is an intracellular checkpoint for interferon gamma sensing.
Ng S; Lim S; Sim ACN; Mangadu R; Lau A; Zhang C; Martinez SB; Chandramohan A; Lim UM; Ho SSW; Chang SC; Gopal P; Hong LZ; Schwaid A; Fernandis AZ; Loboda A; Li C; Phan U; Henry B; Partridge AW
Sci Rep; 2022 Aug; 12(1):14087. PubMed ID: 35982220
[TBL] [Abstract][Full Text] [Related]
24. Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex.
Gu J; Mao W; Ren W; Xu F; Zhu Q; Lu C; Lin Z; Zhang Z; Chu Y; Liu R; Ge D
Cancer Lett; 2019 Feb; 443():125-134. PubMed ID: 30503554
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.
Li Q; Li Z; Wei S; Wang W; Chen Z; Zhang L; Chen L; Li B; Sun G; Xu J; Li Q; Wang L; Xu Z; Xia Y; Zhang D; Xu H; Xu Z
J Exp Clin Cancer Res; 2017 Apr; 36(1):59. PubMed ID: 28431583
[TBL] [Abstract][Full Text] [Related]
26. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.
Liu X; Fu Y; Huang J; Wu M; Zhang Z; Xu R; Zhang P; Zhao S; Liu L; Jiang H
J Exp Clin Cancer Res; 2019 Jul; 38(1):315. PubMed ID: 31315644
[TBL] [Abstract][Full Text] [Related]
27. Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.
Fisher ML; Keillor JW; Xu W; Eckert RL; Kerr C
Mol Cancer Res; 2015 Jul; 13(7):1083-94. PubMed ID: 25934691
[TBL] [Abstract][Full Text] [Related]
28. Chemosensitizing effect of honokiol in oral carcinoma stem cells via regulation of IL-6/Stat3 signaling.
Chang MT; Lee SP; Fang CY; Hsieh PL; Liao YW; Lu MY; Tsai LL; Yu CC; Liu CM
Environ Toxicol; 2018 Nov; 33(11):1105-1112. PubMed ID: 30076764
[TBL] [Abstract][Full Text] [Related]
29. CHIP-mediated degradation of transglutaminase 2 negatively regulates tumor growth and angiogenesis in renal cancer.
Min B; Park H; Lee S; Li Y; Choi JM; Lee JY; Kim J; Choi YD; Kwon YG; Lee HW; Bae SC; Yun CO; Chung KC
Oncogene; 2016 Jul; 35(28):3718-28. PubMed ID: 26568304
[TBL] [Abstract][Full Text] [Related]
30. Transfection of T-Box Transcription Factor
Akimoto N; Nakamura K; Hijioka H; Kume K; Matsumura Y; Sugiura T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453543
[TBL] [Abstract][Full Text] [Related]
31. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
[TBL] [Abstract][Full Text] [Related]
32. STUB1-SMYD2 Axis Regulates Drug Resistance in Glioma cells.
Pan K; Hu B; Wang L; Yuan J; Xu W
J Mol Neurosci; 2022 Sep; 72(9):2030-2044. PubMed ID: 35939202
[TBL] [Abstract][Full Text] [Related]
33. Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk.
Shashar M; Belghasem ME; Matsuura S; Walker J; Richards S; Alousi F; Rijal K; Kolachalama VB; Balcells M; Odagi M; Nagasawa K; Henderson JM; Gautam A; Rushmore R; Francis J; Kirchhofer D; Kolandaivelu K; Sherr DH; Edelman ER; Ravid K; Chitalia VC
Sci Transl Med; 2017 Nov; 9(417):. PubMed ID: 29167396
[TBL] [Abstract][Full Text] [Related]
34. The E3 ubiquitin ligase RNF135 regulates the tumorigenesis activity of tongue cancer SCC25 cells.
Jin J; Zhao L; Li Z
Cancer Med; 2016 Nov; 5(11):3140-3146. PubMed ID: 27709798
[TBL] [Abstract][Full Text] [Related]
35. SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma.
Khammanivong A; Gopalakrishnan R; Dickerson EB
Mol Cancer; 2014 Dec; 13():260. PubMed ID: 25471937
[TBL] [Abstract][Full Text] [Related]
36. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
Zang HL; Ren SN; Cao H; Tian XF
IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
[TBL] [Abstract][Full Text] [Related]
37. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
[TBL] [Abstract][Full Text] [Related]
38. Tissue transglutaminase expression is necessary for adhesion, metastatic potential and cancer stemness of renal cell carcinoma.
Bagatur Y; Ilter Akulke AZ; Bihorac A; Erdem M; Telci D
Cell Adh Migr; 2018 Mar; 12(2):138-151. PubMed ID: 28498731
[TBL] [Abstract][Full Text] [Related]
39. CHIP/Stub1 interacts with eIF5A and mediates its degradation.
Shang Y; Zhao X; Tian B; Wang Y; Ren F; Jia B; Zhai Y; Chen W; He D; Chang Z
Cell Signal; 2014 May; 26(5):1098-104. PubMed ID: 24509416
[TBL] [Abstract][Full Text] [Related]
40. Orai1 promotes tumor progression by enhancing cancer stemness via NFAT signaling in oral/oropharyngeal squamous cell carcinoma.
Lee SH; Rigas NK; Lee CR; Bang A; Srikanth S; Gwack Y; Kang MK; Kim RH; Park NH; Shin KH
Oncotarget; 2016 Jul; 7(28):43239-43255. PubMed ID: 27259269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
